Case Report

J Rheum Dis 2014; 21(2): 77-81

Published online April 30, 2014

© Korean College of Rheumatology

A Case of Tjalma Syndrome Coincidentally Accompanied by an Ovarian Teratoma Successfully Treated with Intravenous Immunoglobulin-G Adjunctive Therapy

Eun-Kyoung Park1, Seung-Geun Lee1, Ik Soo Byon2, Sun-Hee Lee1, Seong-Jun Lee1, Yoon-Jeong Nam1, Ji-Hye Park1, Geun-Tae Kim3, Young-Eun Park4, Seong-Hu Park5, Joung-Wook Lee6, Jun-Hee Lee7, Seung-Hoon Baek7

Department of Internal Medicine, Pusan National University School of Medicine1, Busan, Department of Ophthalmology, Pusan National University Yangsan Hospital2, Yangsan, Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine3, Malgeunsem Hospital4, Changwon, Young-do Hospital5, Busan St. Mary’s Medical Center6, Department of Internal Medicine, Ilsin Christian Hospital7, Busan, Korea

Correspondence to : Seung-Geun Lee

Received: April 22, 2013; Revised: June 16, 2013; Accepted: June 17, 2013

Abstract

Tjalma or pseudo-pseudo Meigs’ syndrome is a clinical con-dition that is characterized with ascites, pleural effusion, and increased serum CA-125 levels in patients with systemic lu-pus erythematosus (SLE) without the presence of ovarian tumor. On the other hand, Meigs’ and pseudo-Meigs’ syn-dromes represent the same manifestations with ovarian tumor. In this case report, we present a 43-year-old SLE pa-tient suffering from Tjalma syndrome with the coexistence of incidental ovarian teratoma, who was successfully treated with intravenous immunoglobulin-G adjunctive therapy af-ter inadequate response to surgical excision of the ovarian tumor, steroid, and cyclophosphamide pulse therapy.

Keywords Systemic lupus erythematosus, Intravenous im-munoglobulin, Ascites, Pleural effusion

Article

Case Report

J Rheum Dis 2014; 21(2): 77-81

Published online April 30, 2014

Copyright © Korean College of Rheumatology.

A Case of Tjalma Syndrome Coincidentally Accompanied by an Ovarian Teratoma Successfully Treated with Intravenous Immunoglobulin-G Adjunctive Therapy

Eun-Kyoung Park1, Seung-Geun Lee1, Ik Soo Byon2, Sun-Hee Lee1, Seong-Jun Lee1, Yoon-Jeong Nam1, Ji-Hye Park1, Geun-Tae Kim3, Young-Eun Park4, Seong-Hu Park5, Joung-Wook Lee6, Jun-Hee Lee7, Seung-Hoon Baek7

Department of Internal Medicine, Pusan National University School of Medicine1, Busan, Department of Ophthalmology, Pusan National University Yangsan Hospital2, Yangsan, Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine3, Malgeunsem Hospital4, Changwon, Young-do Hospital5, Busan St. Mary’s Medical Center6, Department of Internal Medicine, Ilsin Christian Hospital7, Busan, Korea

Correspondence to:Seung-Geun Lee

Received: April 22, 2013; Revised: June 16, 2013; Accepted: June 17, 2013

Abstract

Tjalma or pseudo-pseudo Meigs’ syndrome is a clinical con-dition that is characterized with ascites, pleural effusion, and increased serum CA-125 levels in patients with systemic lu-pus erythematosus (SLE) without the presence of ovarian tumor. On the other hand, Meigs’ and pseudo-Meigs’ syn-dromes represent the same manifestations with ovarian tumor. In this case report, we present a 43-year-old SLE pa-tient suffering from Tjalma syndrome with the coexistence of incidental ovarian teratoma, who was successfully treated with intravenous immunoglobulin-G adjunctive therapy af-ter inadequate response to surgical excision of the ovarian tumor, steroid, and cyclophosphamide pulse therapy.

Keywords: Systemic lupus erythematosus, Intravenous im-munoglobulin, Ascites, Pleural effusion

JRD
Jan 01, 2025 Vol.32 No.1, pp. 1~7
COVER PICTURE
Cumulative growth of rheumatology members and specialists (1980~2024). Cumulative distribution of the number of the (A) Korean College of Rheumatology members and (B) rheumatology specialists. (J Rheum Dis 2025;32:63-65)

Stats or Metrics

Share this article on

  • line

Related articles in JRD

Journal of Rheumatic Diseases

pISSN 2093-940X
eISSN 2233-4718
qr-code Download